EMCTO 2011: Significance of the ALK Marker in non-smoker lung cancer patients

EMCTO 2011: Significance of the ALK Marker in non-smoker lung cancer patients

Video Analysis for EMCTO 2011: Significance of the ALK Marker in non-smoker lung cancer patients

May 29, 2014

600 x 360

05:07

5 / 5 (0 ratings)

OVERVIEW

  • A

    FINAL GRADE

  • 5 / 5

    RATING

  • 0

    VIEWS

  • 0

    LIKES

ACHIEVEMENTS

  • USER
    SATISFACTION

  • TEACHER'S
    PET

  • TWO YEARS
    ONLINE

REVENUE

  • $0

    EST. TOTAL REVENUE

  • $0 - $0

    EST. MONTHLY REVENUE

  • $0 - $0

    EST. YEARLY REVENUE

GROWTH

  • 0

    AVG. DAILY VIEWS

  • 0

    AVG. DAILY LIKES

  • 0

    AVG. DAILY DISLIKES

* We try our best to gather the video's growth rate. This is an estimate for a cumulative growth of views.

VIDEO

EMCTO 2011: Significance of the ALK Marker in non-smoker lung cancer patients

0

Prof Ping Yang, Mayo Clinic, Rochester, USA talks about non-smoker lung cancer sufferers who test positive for the ALK (anaplastic lymphoma kinase) marker have a more aggressive form of cancer that is considerably more likely to progress and recur. Prof Ping Yang discusses the IHC and FISH techniques that are used to detect the ALK marker and explains when clinicians can use IHC and when it is necessary to use FISH. Prof Yang outlines the prevalence of the ALK marker within non-smoker lung cancer patients and talks about the potential for targeted therapies to treat this patient population.

SOCIAL ACTIVITY

  • 0 SHARES

  • 0 TWEETS

  • 0 +1's

  • 0 PINS

  • 0 SHARES

WEB RESULTS

  • ecancer.org   Significance of the ALK Marker in non-smoker lung cancer …

    EMCTO 2011 / Significance of the ALK Marker in non-smoker lung cancer patients. 24th - 26th Feb 2011

    http://ecancer.org/conference/99-emcto-2011/video/853/significance-of-the-alk-marker-in-non-smoker-lung-cancer-patients.php

  • www.youtube.com   EMCTO 2011: Significance of the ALK Marker in …

    ... USA talks about non-smoker lung cancer sufferers who test positive for the ALK (anaplastic lymphoma kinase) marker ... non-smoker lung cancer ...

    http://www.youtube.com/watch?v=XbdIto9xuVg

  • ecancer.org   Significance of the ALK Marker in non-smoker lung cancer …

    Significance of the ALK Marker in non-smoker lung cancer patients. ... of the ALK marker within non-smoker lung cancer patients and talks ... · EMCTO 2011 …

    http://ecancer.org/video/853/significance-of-the-alk-marker-in-non-smoker-lung-cancer-patients.php

  • www.youtube.com   EMCTO 2011: Stereotactic radiosurgery for …

    Dr Rafael Dziadziuszko, Medical University of Gdansk, Poland, talks about stereotactic radiosurgery for stage I non-small cell lung cancer. This technology ...

    http://www.youtube.com/watch?v=3C5KS8E5LqA

  • crosswords911.com   Anaplastic Definition. Crossword Dictionary.

    Anaplastic carcinoma of the thyroid (ATC) is an aggressive form of cancer of the thyroid gland; it represents of a thyroid tumor to anaplastic one; it may account for ...

    http://crosswords911.com/anaplastic.html

  • www.symposier.com   Symposier

    Contact: , Cancer Conference Secretariat , NCRI Phone: 011-44-20-3469-5453 Email: ncriconference@ncri.org.uk. Learn more... By Symposier. Medical Doctor | United ...

    http://www.symposier.com/events/events.php?spec=mine

  • www.nejm.org   Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

    Non–small-cell lung cancer with sensitive ... rank test and a two-sided significance level of 5%. Setting the duration of enrollment to 2 years with a minimum follow-up period of 6 months, we initially planned to enroll 320 patients.

    The New England Journal of Medicine   •   7 years ago

    http://www.nejm.org/doi/full/10.1056/NEJMoa0909530

  • www.ncbi.nlm.nih.gov   Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status

    We only found EGFR (8.0%), c-Met (2.8%), and PIK3CA (2.6%) alterations in the non-smoker with squamous ... PTEN, EML4-ALK fusion gene, DDR2, and FGFR2 in a population of Chinese patients with primary lung cancer. A total of 1800 patients were …

    ncbi.nlm.nih.gov   •   6 years ago

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387024/

  • www.nature.com   ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation

    The clinical significance ... ASCL1 expression is much more frequent in AD than in SQCC. Each gene is represented by the most variable probeset with the highest s.d. Expression levels of known NE markers were examined in the Mayo Clinic lung cancer …

    Nature   •   4 years ago

    http://www.nature.com/onc/journal/v33/n29/full/onc2013359a.html

  • Show More